Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05318313 · ClinicalTrials.gov registry record

Telerehabilitation for TMD

A clinical trial, sponsored by University of Minnesota.

Completed
Registry status
207
Enrollment target

NCT05318313: Completed study, sponsored by University of Minnesota.

NCT05318313 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 207 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05318313 has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
207 participants
Enrollment target

Study Summary

This study will compare after physical therapy for Temporomandibular Disorders (TMD) performed either in-person or virtually using telerehabilitation. Comparing diagnostic reliability and quality-of-life outcomes in each group will determine (based on a 10% margin) whether delivering physical therapy via telerehabilitation is as good as standard in-person care for these individuals. Long term outcomes including patient satisfaction, cost-effectiveness analysis, and functional status will describe the feasibility of telerehabilitation as a management intervention for this population.

Primary Outcome

Diagnosis will be determined by putting clinical assessment results into the Brief Diagnostic Criteria for TMD (Brief DC/TMD) algorithm and getting one or more of 7 possible diagnoses: TMJ arthralgia (joint), Masticatory myofascial pain (muscle), TMJ disc displacement with reduction (joint), TMJ disc displacement without reduction (joint), TMJ arthritis (joint), TMD headache (muscle), other (neither). The diagnosis will be measured as one of four options: 1. joint; 2. muscle; 3. both; or 4. neit

Interventions

  • OTHER Telerehabilitation

Trial Details

FieldValue
Enrollment Target 207 participants
Start Date 2022-06-17
Est. Completion 2024-07-01
University of Minnesota

966 total trials

What the finished NCT05318313 record still lists

NCT05318313 is an observational study that tracks outcomes without assigning an intervention. The registered 207 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Telerehabilitation is the first listed.

NCT05318313 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05318313 about?

NCT05318313 is a clinical study titled "Telerehabilitation for TMD". This study will compare after physical therapy for Temporomandibular Disorders (TMD) performed either in-person or virtually using telerehabilitation. Comparing diagnostic reliability and quality-of-life outcomes in each group will determine (based on a 10% margin) whether delivering physical therap...

What is the current status of trial NCT05318313?

This trial is currently completed. The enrollment target is 207 participants. The study started on 2022-06-17. Estimated completion is 2024-07-01.

What interventions are being tested in trial NCT05318313?

The interventions under investigation include: Telerehabilitation (OTHER).

Who is sponsoring clinical trial NCT05318313?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04353778 · 207 participants · Phase 1

    Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV

  • NCT05875805 · 207 participants · NA

    A Telehealth Advance Care Planning Intervention

  • NCT06254950 · 207 participants · Phase 2

    A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

  • NCT06904274 · 207 participants · Phase 3

    Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05318313, the US trial registry maintained by the National Library of Medicine. NCT05318313 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.